Search results

Filter

Filetype

Your search for "*" yielded 534508 hits

Djurhållning ledde till en cocktail av nya sjukdomar

Kranium med spår av hepatit B, påträffat vid Kolyma-floden i östra Sibirien. Foto: Vladimir Pitulko En omfattande studie på forntida människo-dna slår fast det forskarna tidigare anat men inte fullt ut kunna bekräfta. Människan drabbades av ett stort antal nya sjukdomar i samband med att våra förfäder började domesticera djur. I studien, som publiceras i den vetenskapliga tidskriften Nature, har e

https://www.lu.se/artikel/djurhallning-ledde-till-en-cocktail-av-nya-sjukdomar - 2025-08-22

Welcome to an Open House at CMES!

Welcome to CMES on 5th September to meet our staff and learn more about our research, activities and Arabic language courses! Enjoy some Arabic sweets, mingle with our staff, and learn more about our Arabic language courses. CMES offers several Arabic language courses during the fall of 2025, exclusively for Lund University students and staff interested in working and conducting research in Arabic

https://www.cmes.lu.se/article/welcome-open-house-cmes-0 - 2025-08-22

Karin Aggestam om utsikterna till en rättvis fred i Israel Palestina

Karin Aggestam har bidragit med en artikel i Forskning & Framsteg om utsikterna till en rättvis fred i Israel Palestina. Hon presenterar artikeln vid ett panelsamtal om rättvisa den 6 oktober kl. 19.00 på Playhouse Teater, Stockholm. Läs artikeln här: https://fof.se/artikel/ar-en-rattvis-fred-mellan-israel-och-palestina-mojlig/RJ:s årsbok: https://www.rj.se/samverkan/arsboken/rattvisa/Mer om panel

https://www.svet.lu.se/artikel/karin-aggestam-om-utsikterna-till-en-rattvis-fred-i-israel-palestina - 2025-08-22

“The best of both worlds” – Heiner Linke on why Swedish researchers should invest in innovation

For me, the result has been better grant applications, better utilisation, and research that solves real problems, says Heiner Linke. Photo: Kennet Ruona Can innovation strengthen research? Former NanoLun director Heiner Linke, professor of nanophysics and member of the Royal Swedish Academy of Sciences, achieved this by combining research and innovation. His own attitude towards utilisation and i

https://www.nano.lu.se/article/best-both-worlds-heiner-linke-why-swedish-researchers-should-invest-innovation - 2025-08-22

New beamline at MAX IV to contribute to sustainable materials and green technology

With funding from the Wallenberg Initiative Material Science for Sustainability (WISE) MAX IV Laboratory will be able to expand with the beamline TomoWISE for full-field tomography. WISE Photo: Johan Persson MAX IV is awarded 200 million SEK from Knut and Alice Wallenberg Foundation and WISE to construct and establish a 3D imaging X-ray technology aimed at studying and developing advanced material

https://www.nano.lu.se/article/new-beamline-max-iv-contribute-sustainable-materials-and-green-technology - 2025-08-22

HAIDI researchers at NORDMEDIA 2025

Frida Morris presenting At the NORDMEDIA 2025 conference in Odense (August 13-15), researchers from the HAIDI project – Anette Grønning (University of Southern Denmark), Amalie Søgaard Nielsen (University of Southern Denmark), Freja Morris (Lund University), Fredrika Thelandersson (Lund University) and Helena Sandberg (Lund University) – presented new work on digitalisation and care. Two papers we

https://www.iko.lu.se/en/article/haidi-researchers-nordmedia-2025 - 2025-08-22

Hjelt Diabetes Foundation ger stöd åt forskning som kan bana väg för nya cellterapier

Sevda Gheibi studerar ett protein som kallas ACSL1 som har visat sig spela en viktig roll för funktionen hos betaceller. Hon får ett stipendium från Hjelt Diabetes Foundation för fortsatta studier av proteinet. Foto: Petra Olsson Typ 2-diabetes är en kronisk sjukdom som oftast kräver livslång behandling. Ett viktigt mål inom diabetesforskningen är att utveckla cellterapier som kan bota sjukdomen.

https://www.medicin.lu.se/artikel/hjelt-diabetes-foundation-ger-stod-forskning-som-kan-bana-vag-nya-cellterapier - 2025-08-22

Hjelt Diabetes Foundation supports research that can pave the way for new cell therapies

Sevda Gheibi studies a protein called ACSL1 that seems to play a key role for beta cell function. She receives a grant of from the Hjelt Diabetes Foundation for further studies of this protein. Photo: Petra Olsson Type 2 diabetes is a chronic disease that usually requires lifelong treatment. A central goal for many diabetes researchers is to develop new cell therapies that can cure the disease. Th

https://www.medicine.lu.se/article/hjelt-diabetes-foundation-supports-research-can-pave-way-new-cell-therapies - 2025-08-22